Vosoughi T - Search Results

1

Significance of Inactivated Genes in Leukemia: Pathogenesis and Prognosis.

Heidari N, Abroun S, Bertacchini J, Vosoughi T, Rahim F, Saki N. Heidari N, et al. Among authors: vosoughi t. Cell J. 2017 Spring;19(Suppl 1):9-26. doi: 10.22074/cellj.2017.4908. Epub 2017 May 17. Cell J. 2017. PMID: 28580304 Free PMC article. Review.

2

BRAF Mutation in Hairy Cell Leukemia.

Ahmadzadeh A, Shahrabi S, Jaseb K, Norozi F, Shahjahani M, Vosoughi T, Hajizamani S, Saki N. Ahmadzadeh A, et al. Among authors: vosoughi t. Oncol Rev. 2014 Sep 23;8(2):253. doi: 10.4081/oncol.2014.253. eCollection 2014 Sep 23. Oncol Rev. 2014. PMID: 25992240 Free PMC article. Review.

3

The Role of HDACs as Leukemia Therapy Targets using HDI.

Ahmadzadeh A, Khodadi E, Shahjahani M, Bertacchini J, Vosoughi T, Saki N. Ahmadzadeh A, et al. Among authors: vosoughi t. Int J Hematol Oncol Stem Cell Res. 2015 Oct 1;9(4):203-14. Int J Hematol Oncol Stem Cell Res. 2015. PMID: 26865932 Free PMC article.

4

Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells.

Norozi F, Ahmadzadeh A, Shahrabi S, Vosoughi T, Saki N. Norozi F, et al. Among authors: vosoughi t. Tumour Biol. 2016 Sep;37(9):11679-11689. doi: 10.1007/s13277-016-5187-7. Epub 2016 Jul 20. Tumour Biol. 2016. PMID: 27440203 Review.

5

How is the relationship between TWIST-1 and BCR-ABL1 gene expressions in chronic myeloid leukaemia patients?

Heidari N, Vosoughi T, Mohammadi Asl J, Saki Malehi A, Saki N. Heidari N, et al. Among authors: vosoughi t. Biomarkers. 2018 Jan 12:1-6. doi: 10.1080/1354750X.2018.1423705. Online ahead of print. Biomarkers. 2018. PMID: 29297244

6

CD markers variations in chronic lymphocytic leukemia: New insights into prognosis.

Vosoughi T, Bagheri M, Hosseinzadeh M, Ehsanpour A, Davari N, Saki N. Vosoughi T, et al. J Cell Physiol. 2019 Nov;234(11):19420-19439. doi: 10.1002/jcp.28724. Epub 2019 May 2. J Cell Physiol. 2019. PMID: 31049958 Review.

7

Essential thrombocythemia: a hemostatic view of thrombogenic risk factors and prognosis.

Maleknia M, Shahrabi S, Ghanavat M, Vosoughi T, Saki N. Maleknia M, et al. Among authors: vosoughi t. Mol Biol Rep. 2020 Jun;47(6):4767-4778. doi: 10.1007/s11033-020-05536-x. Epub 2020 May 30. Mol Biol Rep. 2020. PMID: 32472297 Review.

8

Evaluation of immunophenotypic markers and clinico-hematological profile in chronic lymphocytic leukemia: implications for prognosis.

Bagheri M, Vosoughi T, Hosseinzadeh M, Saki N. Bagheri M, et al. Among authors: vosoughi t. BMC Res Notes. 2020 Sep 3;13(1):412. doi: 10.1186/s13104-020-05243-7. BMC Res Notes. 2020. PMID: 32883360 Free PMC article.

9

Evaluation of HLA-B*05, *07, *08, *27 and *51 Allele Expression in Adults with Immune Thrombocytopenic Purpura.

Rad NY, Vosoughi T, Ehsanpour A, Saki N, Pezeshki SMS. Rad NY, et al. Among authors: vosoughi t. Maedica (Bucur). 2023 Mar;18(1):61-66. doi: 10.26574/maedica.2023.18.1.61. Maedica (Bucur). 2023. PMID: 37266468 Free PMC article.

10

Therapeutic effect of ferrous sulfate in diabetic patients with iron deficiency anaemia: a randomised controlled trial.

Taati B, Ganji R, Moradi L, Vosoughi T, Gisouei A. Taati B, et al. Among authors: vosoughi t. Ann Med Surg (Lond). 2024 Feb 15;86(4):1989-1996. doi: 10.1097/MS9.0000000000001838. eCollection 2024 Apr. Ann Med Surg (Lond). 2024. PMID: 38576965 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page